Intellia Therapeutics, Inc.
NTLA · Healthcare · · USDFahodi Score SELL Long-term (Investment)
45
/ 100
Technical
0
Trend & RS
44
Momentum
38
Fundamental
61
Macro
24
Liquidity
54
| Component | Score | Weight |
|---|---|---|
| Technical | 0.0 | 10% |
| Trend & RS | 43.7 | 10% |
| Momentum | 37.7 | 5% |
| Fundamental | 61.1 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 54.4 | 20% |
Trade Setup
| Entry | 11.19 |
| Stop Loss | 9.55 (14.7%) |
| Target 1 (1:1) | 12.83 (+14.7%) |
| Target 2 (2:1) | 14.47 (+29.3%) |
| ATR(14) | 0.82 (7.3%) |
| Risk per Share | 1.64 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 85.0 | +1.40 | |
| Momentum | 37.7 | -0.49 | |
| Quality | 40.0 | -0.40 | |
| Composite | 54.2 | ||
Quality Scores
Piotroski F-Score
2
/9 —
Weak
✗
✗
✗
✗
✓
✓
✗
✗
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
7.70
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | N/A | 22.0 | Inline |
| P/B Ratio | 1.9 | 4.0 | Below |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
28.82%
Full Kelly
14.41%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 45/100. Estimated win rate 54%, avg win 7.7%, avg loss 4.1%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG SELL
0
Bullish Signals
4
Bearish Signals
43.53
RSI(14)
-0.1042
MACD
Relative Strength (RS) WEAKENING
71
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↓ FALLING (-1.9% vs SPY 3M) |
| RS vs Sector | UNDERPERFORMING (Healthcare) |
| RS New High | No (52d since high) |
| Sector Outperformance | -19.7% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
WEAKENING:
Losing momentum — the stock was performing well but is now falling behind the market.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 43.53 | NEUTRAL |
| Macd | -0.1042 | BEARISH |
| Ma Cross | 12.09 / 13.04 | DEATH CROSS |
| Trend Short | BELOW SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.04x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 18.48 |
| Bollinger Upper | 13.17 |
| SMA(200) | 13.04 |
| SMA(50) | 12.09 |
| SMA(20) | 11.84 |
| Current Price | 11.10 |
| Bollinger Lower | 10.51 |
| 52-Week Low | 7.95 |
| ATR(14) | 0.82 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
Insufficient data for Wyckoff analysis.
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.92x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.69x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 0.75x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.81x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Demand | 0.04x | Low volume, narrow spread, weak close — no buying interest |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 12.40 | Above Kijun |
| Kijun-sen (26) | 12.26 | Base line |
| Senkou A | 12.33 | Leading span A |
| Senkou B | 12.26 | Leading span B |
| Cloud | 12.26 – 12.33 | Bullish (Green) |
| Price vs Cloud | 11.19 | Below Cloud |
| Chikou Span | 12.26 | Bearish |
| Alignment Score | 2/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH FADING
BB: 10.51 – 13.17 | KC: 10.64 – 13.04
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bullish | MACD | 12 |
Anchored VWAP
VWAP: 12.74
Anchor: 2025-11-20 (52w Low)
BELOW AVWAP
-12.1%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/NTLA
Valuation
| Metric | Value |
|---|---|
| Market Cap | 1.56B |
| P/E (TTM) | N/A |
| Forward P/E | N/A |
| P/B | 1.92 |
| EPS | -3.35 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | -46.2% |
| Profit Margin | N/A |
| ROE | -55.4% |
| Debt/Equity | 10.09 |
| Current Ratio | 6.65 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 1.82 |
Trading Data
11.10
Open
11.10
Day High
11.10
Day Low
7.60M
Volume (1.7x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)